MRK INVESTOR DEADLINE: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
February 20, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025, ...
Merck & Co., Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / February 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...
AOL16d
Merck beats estimates on Q4 earnings, stock slides on tepid 2025 guidance
Merck reported $64.2 billion in sales for 2024, a 7% increase compared with 2023. That is near Wall Street's consensus of $64 billion. Earnings per share came in at $7.65, just above Wall Street's ...
Hosted on MSN16d
Merck Stock Plummets 9% As Gardasil Dynamics, 2025 Guidance Weigh On Shares
Investors hammered Merck stock Tuesday after the company beat fourth-quarter expectations, but delivered a light 2025 outlook.